Neurosurgeons stand at the interface of life-saving intervention and microscopic precision. Their expertise spans trauma, oncology, vascular malformations, and functional disorders—often delivered within high-stakes environments requiring rapid decision-making and flawless execution. Whether decompressing intracranial pressure after severe head injury or implanting electrodes for deep brain stimulation, neurosurgeons must navigate delicate neuroanatomy without compromising critical structures. Technological advances now allow for image-guided resection, awake craniotomy, and minimally invasive skull base approaches that significantly improve recovery times. As surgical robotics, augmented reality, and intraoperative MRI become standard tools, neurosurgeons are redefining what is operable and when. Beyond the operating room, they play key roles in multidisciplinary teams managing epilepsy, spinal disorders, and congenital abnormalities. In global contexts, disparities in surgical access have made neurosurgeons central to advocacy efforts in surgical equity. Their contributions extend far beyond their instruments—training future specialists, shaping neurosurgical policy, and pushing innovation that continually redefines the possible in brain and spine care.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States